1. Home
  2. GKOS vs EXLS Comparison

GKOS vs EXLS Comparison

Compare GKOS & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$113.41

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Logo ExlService Holdings Inc.

EXLS

ExlService Holdings Inc.

HOLD

Current Price

$42.65

Market Cap

6.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
EXLS
Founded
1998
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.9B
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
GKOS
EXLS
Price
$113.41
$42.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
4
Target Price
$127.71
$54.50
AVG Volume (30 Days)
641.9K
1.2M
Earning Date
02-19-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.94
EPS
N/A
1.48
Revenue
$469,820,000.00
$2,026,490,000.00
Revenue This Year
$31.15
$15.32
Revenue Next Year
$24.15
$11.27
P/E Ratio
N/A
$28.84
Revenue Growth
30.38
14.43
52 Week Low
$73.16
$37.30
52 Week High
$163.71
$52.43

Technical Indicators

Market Signals
Indicator
GKOS
EXLS
Relative Strength Index (RSI) 58.14 58.63
Support Level $109.07 $40.71
Resistance Level $115.00 $43.17
Average True Range (ATR) 2.76 0.70
MACD -0.95 -0.09
Stochastic Oscillator 44.01 65.25

Price Performance

Historical Comparison
GKOS
EXLS

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.

Share on Social Networks: